First Time Loading...
D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 690 KRW 4.06% Market Closed
Updated: May 14, 2024

Wall Street
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 24 990 KRW with a low forecast of 23 230 KRW and a high forecast of 27 300 KRW.

Lowest
Price Target
23 230 KRW
31% Upside
Average
Price Target
24 990 KRW
41% Upside
Highest
Price Target
27 300 KRW
54% Upside
Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets
600200
JiangSu WuZhong Pharmaceutical Development Co Ltd
23% Upside
4519
Chugai Pharmaceutical Co Ltd
31% Upside
600420
Shanghai Shyndec Pharmaceutical Co Ltd
40% Upside
002728
Teyi Pharmaceutical Group Co Ltd
46% Upside
012790
Sinil Pharmaceutical Co Ltd
180% Upside
2348
Dawnrays Pharmaceutical (Holdings) Ltd
124% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
19% Upside

Revenue
Forecast

Revenue Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 2 years is 10%.

14%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 2 years is 23%.

9%
Past Growth
23%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 2 years is 25%.

7%
Past Growth
25%
Estimated Growth
Estimates Accuracy
0%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
24 990 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 24 990 KRW with a low forecast of 23 230 KRW and a high forecast of 27 300 KRW.

What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 2 years is 10%.

What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
23%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 2 years is 23%.

What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 2 years is 25%.